Taysha Gene Therapies, Inc. Quarterly Other Liabilities, Noncurrent in USD from Q4 2020 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.
Summary
Taysha Gene Therapies, Inc. quarterly Other Liabilities, Noncurrent history and growth rate from Q4 2020 to Q4 2024.
  • Taysha Gene Therapies, Inc. Other Liabilities, Noncurrent for the quarter ending December 31, 2024 was $1.31M, a 17% decline year-over-year.
Other Liabilities, Noncurrent, Quarterly (USD)
Other Liabilities, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2024 $1.31M -$268K -17% Dec 31, 2024 10-K 2025-02-26
Q3 2024 $1.36M -$2.47M -64.4% Sep 30, 2024 10-Q 2024-11-13
Q2 2024 $1.38M -$2.54M -64.8% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $1.5M -$2.5M -62.5% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $1.58M -$2.55M -61.8% Dec 31, 2023 10-K 2025-02-26
Q3 2023 $3.83M -$102K -2.59% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3.92M +$442K +12.7% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $4M +$508K +14.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $4.13M +$395K +10.6% Dec 31, 2022 10-K 2024-03-19
Q3 2022 $3.93M +$919K +30.5% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 $3.48M +$2.72M +355% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $3.5M +$2.5M +250% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $3.74M +$3.29M +730% Dec 31, 2021 10-K 2023-03-28
Q3 2021 $3.02M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $765K Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $999K Mar 31, 2021 10-Q 2021-05-11
Q4 2020 $450K Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.